ICD-10-CM Code C77.0

Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck

Version 2021 Billable Code Neoplasm Malignant Secondary

Valid for Submission

C77.0 is a billable code used to specify a medical diagnosis of secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck. The code is valid for the fiscal year 2021 for the submission of HIPAA-covered transactions. The ICD-10-CM code C77.0 might also be used to specify conditions or terms like metastasis to head and neck lymph node, n1: unilateral metastasis in lymph node > 6 cm in greatest dimension, above supraclavicular fossa, n1a: metastasis in ipsilateral cervical lymph node, n2: bilateral metastasis in lymph node > 6 cm in greatest dimension, above supraclavicular fossa, n3b: extension to supraclavicular fossa, neoplasm of breast regional lymph node staging category n3 as per american joint committee on cancer 7th edition, etc

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: Neoplasm, neoplastic lymph, lymphatic channel NEC gland (secondary) auricular (anterior) (posterior) ; Neoplasm, neoplastic lymph, lymphatic channel NEC gland (secondary) cervical ; Neoplasm, neoplastic lymph, lymphatic channel NEC gland (secondary) cervicofacial ; Neoplasm, neoplastic lymph, lymphatic channel NEC gland (secondary) face ; Neoplasm, neoplastic lymph, lymphatic channel NEC gland (secondary) head ; Neoplasm, neoplastic lymph, lymphatic channel NEC gland (secondary) jugular ; Neoplasm, neoplastic lymph, lymphatic channel NEC gland (secondary) mandibular ; etc

ICD-10:C77.0
Short Description:Sec and unsp malig neoplasm of nodes of head, face and neck
Long Description:Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code C77.0:

Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Secondary and unspecified malignant neoplasm of supraclavicular lymph nodes

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Metastasis to head and neck lymph node
  • N1: Unilateral metastasis in lymph node > 6 cm in greatest dimension, above supraclavicular fossa
  • N1a: Metastasis in ipsilateral cervical lymph node
  • N2: Bilateral metastasis in lymph node > 6 cm in greatest dimension, above supraclavicular fossa
  • N3b: extension to supraclavicular fossa
  • Neoplasm of breast regional lymph node staging category N3 as per American Joint Committee on Cancer 7th edition
  • Neoplasm of breast regional lymph node staging category N3c: Metastasis in ipsilateral supraclavicular lymph node
  • Neoplasm of lymph node of face
  • Neoplasm of lymph node of face
  • Neoplasm of occipital lymph nodes
  • Neoplasm of parotid lymph nodes
  • Neoplasm of retropharyngeal lymph nodes
  • Neoplasm of scalene lymph nodes
  • Neoplasm of submandibular lymph nodes
  • Neoplasm of supraclavicular lymph nodes
  • Neoplasm of supraclavicular region
  • pM1a: Distant metastasis
  • pM1a: Metastasis in cervical nodes
  • pN1: Unilateral metastasis in lymph node
  • pN1a category
  • pN1a: Metastasis to level VI
  • pN2: Bilateral metastasis in lymph node
  • pN3: Metastasis in a lymph node
  • pN3: Metastasis in the contralateral mediastinal, internal mammary, or hilar lymph node
  • pN3b category
  • pN3b: Metastasis in lymph node
  • pN3c category
  • pN3c: Metastasis in ipsilateral supraclavicular lymph nodes
  • Secondary malignant neoplasm of lymph nodes of face
  • Secondary malignant neoplasm of lymph nodes of head
  • Secondary malignant neoplasm of lymph nodes of neck
  • Secondary malignant neoplasm of lymph nodes of neck
  • Secondary malignant neoplasm of lymph nodes of neck from thyroid
  • Secondary malignant neoplasm of occipital lymph nodes
  • Secondary malignant neoplasm of parotid lymph nodes
  • Secondary malignant neoplasm of preauricular lymph nodes
  • Secondary malignant neoplasm of retropharyngeal lymph nodes
  • Secondary malignant neoplasm of scalene lymph nodes
  • Secondary malignant neoplasm of submandibular lymph nodes
  • Secondary malignant neoplasm of submaxillary gland
  • Secondary malignant neoplasm of submental lymph nodes
  • Secondary malignant neoplasm of supraclavicular lymph nodes
  • Secondary malignant neoplasm of supraclavicular region
  • Thoracic mesothelioma TNM finding
  • Thyroid TNM finding

Convert C77.0 to ICD-9

  • 196.0 - Mal neo lymph-head/neck

Code Classification

  • Neoplasms (C00–D48)
    • Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80)
      • Secondary and unspecified malignant neoplasm of lymph nodes (C77)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021

Table of Neoplasms

The code C77.0 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »auricular (anterior) (posterior)
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »cervical
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »cervicofacial
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »face
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »head
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »jugular
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »mandibular
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »neck
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »occipital
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »parotid
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »preauricular
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »prelaryngeal
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »pretracheal
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »retropharyngeal
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »scalene
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »sublingual
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »submandibular
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »submaxillary
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »submental
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »supraclavicular
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »lymph, lymphatic channel NEC
    »gland (secondary)
      »Virchow's
C77.0D36.0D48.7D49.89
»Neoplasm, neoplastic
  »Virchow's gland
C77.0C77.0D36.0D48.7D49.89

Information for Patients


Cancer

Also called: Carcinoma, Malignancy, Neoplasms, Tumor

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Most treatment plans may include surgery, radiation and/or chemotherapy. Some may involve hormone therapy, immunotherapy or other types of biologic therapy, or stem cell transplantation.

NIH: National Cancer Institute

  • Cancer (Medical Encyclopedia)
  • Cancer and lymph nodes (Medical Encyclopedia)
  • Cancer treatment -- early menopause (Medical Encyclopedia)
  • Cancer treatment: preventing infection (Medical Encyclopedia)
  • Cancer treatments (Medical Encyclopedia)
  • How to research cancer (Medical Encyclopedia)
  • How to tell your child that you have cancer (Medical Encyclopedia)
  • Hyperthermia for treating cancer (Medical Encyclopedia)
  • Laser therapy for cancer (Medical Encyclopedia)
  • Photodynamic therapy for cancer (Medical Encyclopedia)
  • Targeted therapies for cancer (Medical Encyclopedia)
  • Understanding your cancer prognosis (Medical Encyclopedia)
  • Your cancer care team (Medical Encyclopedia)
  • Your cancer diagnosis: Do you need a second opinion? (Medical Encyclopedia)

[Learn More]